Xiaojing Wang

Papers

Total Citations

H-Index

About

Xiaojing Wang is a clinician-researcher whose work centers on urological oncology, with a particular focus on bladder cancer management and surgical outcomes. Wang's most notable contribution examines the preoperative predictors of early mortality in bladder cancer patients undergoing robot-assisted radical cystectomy, a technically demanding procedure increasingly adopted for its precision and reduced recovery times. Published in 2019 and accumulating 14 citations, this study addresses a critical clinical challenge: identifying, at the time of diagnosis, which laboratory and clinical markers place patients at heightened risk of dying within the early postoperative period. By pinpointing these preoperative factors, Wang's research empowers surgical teams to stratify patient risk more effectively, tailor perioperative care, and ultimately improve survival outcomes. The work sits at the intersection of oncology, minimally invasive surgery, and predictive analytics — a growing and impactful space within urological research. Wang's contributions reflect a commitment to translating preoperative data into actionable clinical decision-making, offering practicing surgeons and oncologists a more evidence-based framework for counseling patients and optimizing treatment planning before they ever enter the operating room.